We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Intermolecular, Inc. (NASDAQGS: IMI) to Merck KGaA, Darmstadt, Germany. Under the terms of the transaction, Intermolecular shareholders will receive $1.20 per share in cash for each share of Intermolecular stock they own.
The Intermolecular merger investigation concerns whether the Board of Intermolecular breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Merck KGaA, Darmstadt, Germany is underpaying for Intermolecular shares, thus unlawfully harming Intermolecular shareholders.
To receive more information, please fill out the form.